epigenetic innovations
Epigenetic Cancer Therapies and the TOPAS Trial- An Interview with Hella Kohlhof
October 02 by Gerald ClarkeFor Dr Hella Kohlhof, the study of epigenetics was not love at first sight, however the potential it posesses eventually won her over. Now Dr Kohlhof is Manager of Translational Pharmacology at 4SC...
Epigenetic Innovations Conference
August 09 by Pharma IQClinically-approved epigenetic therapies are currently effective in only one area: leukaemia. But this belies their true potential. Treatments in development are rapidly expanding across disciplinar...
Epigenetic Trends in Technology and Research
August 05 by Pharmaceuticals & Biotechnology Editor
Enal Razvi, PhD is biotechnology analyst and Managing Director US at Select Biosciences He spoke to Pharma IQ about his recent report on Epigenetic research classes and Assay Trends with...
Adapting Traditional Drug Development Methods for Epigenetic Therapies- Peter Staller
July 05 by Pharmaceuticals & Biotechnology Editor
Peter Staller Director of Oncology Research at Epitherapeutics talks to Pharma IQ about the differences between traditional drug development techniques and those required for development of a epigen...
Adapting Traditional Drug Development Methods for Epigenetic Therapies- Peter Staller
June 21 by Gerald ClarkePeter Staller Director of Oncology Research at Epitherapeutics talks to Pharma IQ about the differences between traditional drug development techniques and those required for development of a epigen...
Novel Antimalarial Drugs Through Epigenetics- Dr Matthew Fuchter
June 05 by Gerald ClarkeMalaria is one of the world's largest public health problems and treatments for the disease still leave a lot to be desired. Dr Matthew Fuchter and his team have taken a novel approach to malari...
